• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract Drug survival of etanercept was significantly lower than other biologics in patients with hidradenitis suppurativa

byKathleen Lau
December 23, 2021
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis

Atopic dermatitis activity is not associated with cardiovascular risk

Oral remibrutinib hits Phase 3 primary endpoint for inducible hives

Tags: adalimumabAnakinraantibioticbiologicbiologic naivebiologicsbiosimilarc-reactive protein (CRP)certolizumab pegoldermdermatologydiscontinuationdrugdrug discontinuationdrug survivaldrug survival patternsetanerceptgolimumabHidradenitis suppurativaInfliximabSecukinumabskinustekinumab
Previous Post

Wellness Check: Addictions

Next Post

Severe gastrointestinal involvement in children with SARS-CoV-2 infection and multisystem inflammatory syndrome

RelatedReports

Brodalumab effective in treating active psoriatic arthritis
Chronic Disease

Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis

June 5, 2026
Eczema more prevalent among older adults than previously thought
Cardiology

Atopic dermatitis activity is not associated with cardiovascular risk

April 2, 2026
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
All Specialties

Oral remibrutinib hits Phase 3 primary endpoint for inducible hives

March 5, 2026
USPSTF recommends routinely screening asymptomatic women for chlamydia and gonorrhea
Infectious Disease

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

January 14, 2026
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Severe gastrointestinal involvement in children with SARS-CoV-2 infection and multisystem inflammatory syndrome

2 Minute Rewind November 29, 2021

Co-occurring substance use disorders are common in pregnant women

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • High intake of sugar-sweetened beverages is associated with increased risk of hepatocellular carcinoma
  • Pediatric hospitals adopt generative AI for documentation and care coordination
  • Hospitals face a new test of artificial intelligence governance
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.